Surpass Medical Acquired by Stryker Corporation
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected